Metraipolis › archive › dc_9e41819feb41

Impact of the COVID-19 pandemic on routine HIV care and antiretroviral treatment outcomes in Kenya: A nationally representative analysis — Europe PMC PMID:38011132

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38011132
DOI
10.1371/journal.pone.0291479
License (as archived)
CC0-1.0
Archived
2026-10-07T11:58:55.064Z
SHA-256 of the archived text
f4494d0fe086be37f1efcc6689d60b5b17d6ae18f4baaac97403fa241c007391
Stable URL of this page
https://metraipolis.com/documento/dc_9e41819feb41

How to cite

Impact of the COVID-19 pandemic on routine HIV care and antiretroviral treatment outcomes in Kenya: A nationally representative analysis — Europe PMC PMID:38011132 — Europe PMC (en), https://europepmc.org/article/MED/38011132 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_9e41819feb41 (Metraipolis archive dc_9e41819feb41, sha256 f4494d0fe086be37f1efcc6689d60b5b17d6ae18f4baaac97403fa241c007391)
BibTeX
@misc{dc9e41819feb41,
  title = {Impact of the COVID-19 pandemic on routine HIV care and antiretroviral treatment outcomes in Kenya: A nationally representative analysis — Europe PMC PMID:38011132},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38011132},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_9e41819feb41; sha256 f4494d0fe086be37f1efcc6689d60b5b17d6ae18f4baaac97403fa241c007391},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38011132. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: The COVID-19 pandemic adversely disrupted global health service delivery. We aimed to assess impact of the pandemic on same-day HIV diagnosis/ART initiation, six-months non-retention and initial virologic non-suppression (VnS) among individuals starting antiretroviral therapy (ART) in Kenya. Methods: Individual-level longitudinal service delivery data were analysed. Random sampling of individuals aged >15 years starting ART between April 2018 -March 2021 was done. Date of ART initiation was stratified into pre-COVID-19 (April 2018 -March 2019 and April 2019 -March 2020) and COVID-19 (April 2020 -March 2021) periods. Mixed effects generalised linear, survival and logistic regression models were used to determine the effect of COVID-19 pandemic on same-day HIV diagnosis/ART initiation, six-months non-retention and VnS, respectively. Results: Of 7,046 individuals sampled, 35.5%, 36.0% and 28.4% started ART during April 2018 -March 2019, April 2019 -March 2020 and April 2020 -March 2021, respectively. Compared to the pre-COVID-19 period, the COVID-19 period had higher same-day HIV diagnosis/ART initiation (adjusted risk ratio [95% CI]: 1.09 [1.04-1.13], p<0.001) and lower six-months non-retention (adjusted hazard ratio [95% CI]: 0.66 [0.58-0.74], p<0.001). Of those sampled, 3,296 (46.8%) had a viral load test done at a median 6.2 (IQR, 5.3-7.3) months after ART initiation. Compared to the pre-COVID-19 period, there was no significant difference in VnS during the COVID-19 period (adjusted odds ratio [95% CI]: 0.79 [95%% CI: 0.52-1.20], p = 0.264). Conclusions: In the short term, the COVID-19 pandemic did not have an adverse impact on HIV care and treatment outcomes in Kenya. Timely, strategic and sustained COVID-19 response may have played a critical role in mitigating adverse effects of the pandemic and point towards maturity, versatility and resilience of the HIV program in Kenya. Continued monitoring to assess long-term impact of the COVID-19 pandemic on HIV care and treatment program in Kenya is warranted.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2023 (prima pubblicazione 2023-11-27).
Identificativi: PMID 38011132 · PMCID PMC10681195 · DOI 10.1371/journal.pone.0291479.
Descrittori MeSH principali: HIV Infections; Anti-HIV Agents; COVID-19.
Pagina: https://europepmc.org/article/MED/38011132 — https://doi.org/10.1371/journal.pone.0291479. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:29:04.309Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.